Biomarker-driven stimulation

Biomarker-driven stimulation is the organizing principle of closed-loop neuromodulation: identify a measurable neural or behavioral signal that tracks the pathological state, then use it as the feedback variable that triggers or grades the stimulation dose. A useful biomarker is mechanistically linked to symptoms, stable enough to set a threshold, sensable in the presence of stimulation artifact, and specific to the state one wants to treat.

Mature examples are scarce. Subthalamic beta power for Parkinson's disease and electrocorticographic seizure-onset patterns for epilepsy are the best established. Psychiatric applications are harder because the target state (mood, compulsion) lacks an agreed physiological correlate, motivating personalized biomarker discovery (for example an individual's amygdala or limbic gamma feature associated with symptomatic states). Across disorders, finding and validating the biomarker is usually the rate-limiting step, harder than building the stimulator.